GenSight Biologics raised €32M in a Series B round in Jul 2015. The company is based in Paris, France. Investors in the round: Abingworth LLP, Fidelity, HealthCap and 2 others. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
